News & Moves: ORA, TLOG, NICE, DATA

(RTTNews) - ORA Heating Up...

Geothermal company Ormat Technologies Inc. (ORA) has reported another quarter of revenue and earnings growth.

In the third quarter ended September 30, 2014, net income attributable to the company's shareholders is $16.5 million or $0.36 per share on total revenues of $140.2 million. This compares with a net income attributable to the company's shareholders of $13.0 million or $0.28 per share and total revenues of $130.7 million.

For full year 2014, the company has narrowed its total revenue guidance range to be between $550.0 million to $560.0 million from its prior revenue outlook range of $540.0 million to $560.0 million. The Wall Street's average estimate is $554.95 million.

ORA closed Wednesday's trading at $28.54, up 0.25%.

TLOG Is A Stock To Watch...

TetraLogic Pharmaceuticals Corp. (TLOG) has a number of clinical trials evaluating its lead clinical-stage product candidate Birinapant.

A randomized phase II trial of Birinapant in Myelodysplastic Syndromes, initiated in 2Q14, is underway - with interim analysis expected in mid-2015.

Birinapant is also under a phase 1/2 trial in ovarian cancer, and data are expected by the end of this year.

A phase I study of Birinapant in combination with *Conatumumab in subjects with relapsed ovarian cancer is also underway. *Conatumumab (AMG 655) is an investigational product candidate owned by Amgen. Data from the Birinapant/conatumumab program are expected around the end of 2014.

TLOG closed Wednesday's trading at $3.87, down 0.77%.

Why NICE Is Nice...

Israel based NICE Systems (NICE), a provider of software solutions, delivered another quarter of strong performance - reporting 9% increase in non-GAAP revenues and 13% increase in non-GAAP EPS for the third quarter of 2014 compared to last year.

For the fourth quarter, the company sees sequential and year-over-year increase in non-GAAP total revenues and non-GAAP EPS.

Looking ahead to full year 2014, NICE Systems anticipates non-GAAP EPS to be in a range of $2.73 to $2.85 on non-GAAP total revenues of $1,003 million to $1,018 million. The company reported non-GAAP EPS of $2.58 and non-GAAP total revenues of $951.0 million in 2013.

NICE closed Wednesday's trading 9% higher at $44.80.

The Big DATA...

Tableau Software Inc. (DATA), a computer software company, for the first time has reported quarterly revenue of more than $100 million in the three months ended September 30, 2014, driven by strong customer growth and product adoption.

In Q3, 2014, the non-GAAP net income was $3.9 million or $0.06 per share on revenue of $104.5 million. This compared with a non-GAAP net income of $5.6 million or $0.08 per share and revenue of $61.1 million in the year-ago quarter.

Shares of Tableau Software went public on the New York Stock Exchange on May 17, 2013, priced at $31.00 per share. The stock has thus far hit a low of $52.02 and a high of $102.37.